Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
| Delaware District Court | |
| Judge: | Maryellen Noreika |
| Case #: | 1:24-cv-01192 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Oct 24, 2024 |
| Last checked: Thursday Oct 24, 2024 4:12 PM EDT |
|
Defendant
Boehringer Ingelheim International GmbH
|
|
|
Defendant
Boehringer Ingelheim Pharma GmbH & Co. KG
|
|
|
Defendant
Boehringer Ingelheim Pharmaceuticals Inc.
|
|
|
Plaintiff
Sandoz Inc.
|
Represented By
|
| Docket last updated: 1 hours ago |
| Monday, November 04, 2024 | ||
| 10 | 10
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Mon 11/04 2:09 PM
SO ORDERED re9 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 1/9/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 1/9/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 1/9/2025). ORDERED by Judge Maryellen Noreika on 11/4/2024. (dlw) |
|
| 9 | 9
motion
Stipulation to EXTEND Time
Mon 11/04 12:40 PM
STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
| Thursday, October 31, 2024 | ||
| 8 | 8
misc
Redacted Document
Thu 10/31 2:00 PM
REDACTED VERSION of2 Complaint and Exhibits E, F and L by Sandoz Inc.(Gattuso, Dominick) Modified on 10/31/2024 (dlw) |
|
|
Att: 1
Exhibit E,
|
||
|
Att: 2
Exhibit F,
|
||
|
Att: 3
Exhibit L
|
||
| Wednesday, October 30, 2024 | ||
|
utility
Case Assigned/Reassigned
Wed 10/30 11:34 AM
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
||
| Friday, October 25, 2024 | ||
|
order
SO ORDERED
Fri 10/25 8:20 AM
SO ORDERED re1 MOTION to Seal - IT IS HEREBY ORDERED that the motion is GRANTED and the Complaint and Exhibits E, F & L may be filed under seal. IT IS FURTHER ORDERED that redacted versions of these documents shall be filed no later than 10/31/2024. ORDERED by Judge Maryellen Noreika on 10/25/2024. (dlw) |
||
| Thursday, October 24, 2024 | ||
| 7 | 7
misc
Disclosure Statement - Rule 7.1
Thu 10/24 4:19 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Other Affiliate Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (oam) |
|
| 6 | 6
misc
Patent/Trademark Report to Commissioner of Patents
Thu 10/24 4:15 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (oam) |
|
| 5 | 5
misc
ANDA Form
Thu 10/24 4:14 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/20/2022. Date of Expiration of Patent: 06/4/2029 & 06/07/2029. (oam) |
|
| 4 | 4
misc
Exhibit to a Document
Thu 10/24 4:11 PM
EXHIBIT In Support of D.I.2 Complaint filed by Sandoz Inc.(oam) |
|
|
Att: 1
Exhibit B,
|
||
|
Att: 2
Exhibit C,
|
||
|
Att: 3
Exhibit D,
|
||
|
Att: 4
Exhibit G,
|
||
|
Att: 5
Exhibit H,
|
||
|
Att: 6
Exhibit I,
|
||
|
Att: 7
Exhibit J,
|
||
|
Att: 8
Exhibit K,
|
||
|
Att: 9
Exhibit M,
|
||
|
Att: 10
Exhibit N,
|
||
|
Att: 11
Exhibit O,
|
||
|
Att: 12
Exhibit P,
|
||
|
Att: 13
Exhibit Q,
|
||
|
Att: 14
Exhibit R,
|
||
|
Att: 15
Exhibit S
|
||
| 3 | 3
misc
Magistrate Consent Forms
Thu 10/24 4:03 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
|
| 2 | 2
cmp
Complaint
Thu 10/24 4:01 PM
[SEALED] COMPLAINT for PATENT INFRINGEMENT filed against Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4531692.) - filed by Sandoz Inc..(oam) |
|
|
Att: 1
Exhibit E,
|
||
|
Att: 2
Exhibit F,
|
||
|
Att: 3
Exhibit L,
|
||
|
Att: 4
Civil Cover Sheet
|
||
| 1 | 1
8
pgs
motion
Seal
Thu 10/24 3:57 PM
MOTION to File Complaint and Exhibits Under Seal - filed by Sandoz Inc.(oam) |
|
|
Att: 1
Text of Proposed Order
|
||
|
service
No Summons Issued
Thu 10/24 4:21 PM
No Summons Issued. (oam) |
||
|
utility
Remark
Thu 10/24 4:31 PM
Remark: Exit Electronic Copies to Duty Judge MN. (oam) |
||